These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Spatial patterns of heterotopic ossification in fibrodysplasia ossificans progressiva correlate with anatomic temperature gradients. Wang H; De Cunto CL; Pignolo RJ; Kaplan FS Bone; 2021 Aug; 149():115978. PubMed ID: 33915334 [TBL] [Abstract][Full Text] [Related]
5. Neofunction of ACVR1 in fibrodysplasia ossificans progressiva. Hino K; Ikeya M; Horigome K; Matsumoto Y; Ebise H; Nishio M; Sekiguchi K; Shibata M; Nagata S; Matsuda S; Toguchida J Proc Natl Acad Sci U S A; 2015 Dec; 112(50):15438-43. PubMed ID: 26621707 [TBL] [Abstract][Full Text] [Related]
6. The ACVR1 R206H mutation found in fibrodysplasia ossificans progressiva increases human induced pluripotent stem cell-derived endothelial cell formation and collagen production through BMP-mediated SMAD1/5/8 signaling. Barruet E; Morales BM; Lwin W; White MP; Theodoris CV; Kim H; Urrutia A; Wong SA; Srivastava D; Hsiao EC Stem Cell Res Ther; 2016 Aug; 7(1):115. PubMed ID: 27530160 [TBL] [Abstract][Full Text] [Related]
7. Granting immunity to FOP and catching heterotopic ossification in the Act. Kaplan FS; Pignolo RJ; Shore EM Semin Cell Dev Biol; 2016 Jan; 49():30-6. PubMed ID: 26706149 [TBL] [Abstract][Full Text] [Related]
8. Dysregulated BMP signaling through ACVR1 impairs digit joint development in fibrodysplasia ossificans progressiva (FOP). Towler OW; Peck SH; Kaplan FS; Shore EM Dev Biol; 2021 Feb; 470():136-146. PubMed ID: 33217406 [TBL] [Abstract][Full Text] [Related]
9. Cellular Hypoxia Promotes Heterotopic Ossification by Amplifying BMP Signaling. Wang H; Lindborg C; Lounev V; Kim JH; McCarrick-Walmsley R; Xu M; Mangiavini L; Groppe JC; Shore EM; Schipani E; Kaplan FS; Pignolo RJ J Bone Miner Res; 2016 Sep; 31(9):1652-65. PubMed ID: 27027798 [TBL] [Abstract][Full Text] [Related]
10. Elevated BMP and Mechanical Signaling Through YAP1/RhoA Poises FOP Mesenchymal Progenitors for Osteogenesis. Stanley A; Heo SJ; Mauck RL; Mourkioti F; Shore EM J Bone Miner Res; 2019 Oct; 34(10):1894-1909. PubMed ID: 31107558 [TBL] [Abstract][Full Text] [Related]
11. Depletion of Mast Cells and Macrophages Impairs Heterotopic Ossification in an Acvr1 Convente MR; Chakkalakal SA; Yang E; Caron RJ; Zhang D; Kambayashi T; Kaplan FS; Shore EM J Bone Miner Res; 2018 Feb; 33(2):269-282. PubMed ID: 28986986 [TBL] [Abstract][Full Text] [Related]
12. Dysregulation of the BMP-p38 MAPK signaling pathway in cells from patients with fibrodysplasia ossificans progressiva (FOP). Fiori JL; Billings PC; de la Peña LS; Kaplan FS; Shore EM J Bone Miner Res; 2006 Jun; 21(6):902-9. PubMed ID: 16753021 [TBL] [Abstract][Full Text] [Related]
13. ACVR1-Fc suppresses BMP signaling and chondro-osseous differentiation in an in vitro model of Fibrodysplasia ossificans progressiva. Pang J; Zuo Y; Chen Y; Song L; Zhu Q; Yu J; Shan C; Cai Z; Hao J; Kaplan FS; Shore EM; Zhang K Bone; 2016 Nov; 92():29-36. PubMed ID: 27492611 [TBL] [Abstract][Full Text] [Related]
14. The obligatory role of Activin A in the formation of heterotopic bone in Fibrodysplasia Ossificans Progressiva. Alessi Wolken DM; Idone V; Hatsell SJ; Yu PB; Economides AN Bone; 2018 Apr; 109():210-217. PubMed ID: 28629737 [TBL] [Abstract][Full Text] [Related]
15. BMP signaling and skeletal development in fibrodysplasia ossificans progressiva (FOP). Towler OW; Shore EM Dev Dyn; 2022 Jan; 251(1):164-177. PubMed ID: 34133058 [TBL] [Abstract][Full Text] [Related]
16. The serum levels of activin A and bone morphogenetic protein-4 and -6 in patients with fibrodysplasia ossificans progressiva. Ye Z; Wang S; Shan C; Zhu Q; Xue Y; Zhang K Orphanet J Rare Dis; 2023 May; 18(1):111. PubMed ID: 37165433 [TBL] [Abstract][Full Text] [Related]
17. Reduced GS Domain Serine/Threonine Requirements of Fibrodysplasia Ossificans Progressiva Mutant Type I BMP Receptor ACVR1 in the Zebrafish. Allen RS; Jones WD; Hale M; Warder BN; Shore EM; Mullins MC J Bone Miner Res; 2023 Sep; 38(9):1364-1385. PubMed ID: 37329499 [TBL] [Abstract][Full Text] [Related]
18. Functional Testing of Bone Morphogenetic Protein (BMP) Pathway Variants Identified on Whole-Exome Sequencing in a Patient with Delayed-Onset Fibrodysplasia Ossificans Progressiva (FOP) Using ACVR1 Wentworth KL; Lalonde RL; Groppe JC; Brewer N; Moody T; Hansberry S; Taylor KE; Shore EM; Kaplan FS; Pignolo RJ; Yelick PC; Hsiao EC J Bone Miner Res; 2022 Nov; 37(11):2058-2076. PubMed ID: 36153796 [TBL] [Abstract][Full Text] [Related]
19. Heterotopic bone induction via BMP signaling: Potential therapeutic targets for fibrodysplasia ossificans progressiva. Katagiri T; Tsukamoto S; Kuratani M Bone; 2018 Apr; 109():241-250. PubMed ID: 28754575 [TBL] [Abstract][Full Text] [Related]
20. Hints on transcriptional control of essential players in heterotopic ossification of Fibrodysplasia Ossificans Progressiva. Ravazzolo R; Cappato S; Bocciardi R Bone; 2018 Apr; 109():187-191. PubMed ID: 29100956 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]